These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26590124)

  • 1. Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xu L; Wang S; Zhuang L; Lin J; Chen H; Zhu X; Bei W; Zhao Q; Wu H; Meng Z
    Integr Cancer Ther; 2016 Sep; 15(3):349-57. PubMed ID: 26590124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization.
    Yinglu F; Changquan L; Xiaofeng Z; Bai L; Dezeng Z; Zhe C
    J Altern Complement Med; 2009 Feb; 15(2):175-81. PubMed ID: 19216654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization].
    Feng YL; Ling CQ; Li B
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun; 25(6):534-6. PubMed ID: 16025970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization.
    Arslan M; Degirmencioglu S
    Curr Med Imaging Rev; 2019; 15(4):380-385. PubMed ID: 31989907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial.
    Pan Y; Chang R; He Z; Hong M
    Medicine (Baltimore); 2021 Apr; 100(14):e25360. PubMed ID: 33832116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization.
    He JJ; Yin XX; Wang T; Chen MY; Li XL; Yang XJ; Shao HY
    J Cancer Res Ther; 2021 Jul; 17(3):777-783. PubMed ID: 34269313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study.
    Tang CW; Zhu M; Feng WM; Bao Y; Zheng YY
    Drug Des Devel Ther; 2016; 10():2461-6. PubMed ID: 27536066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial.
    Xie J; Chen LH; Ning ZY; Zhang CY; Chen H; Chen Z; Meng ZQ; Zhu XY
    Chin J Cancer; 2017 Jan; 36(1):6. PubMed ID: 28069044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Upasena A; Sirigampala C; de Silva HJ
    BMC Gastroenterol; 2015 Aug; 15():96. PubMed ID: 26239844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study.
    Yang H; Seon J; Sung PS; Oh JS; Lee HL; Jang B; Chun HJ; Jang JW; Bae SH; Choi JY; Yoon SK
    J Vasc Interv Radiol; 2017 Nov; 28(11):1503-1511.e2. PubMed ID: 28941589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of Jianpi Liqi Fang combined with transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and spleen deficiency syndrome.
    Chen X; Wang P; Yang M; Zhou W; Chen J; Meng Z; Su S
    J Tradit Chin Med; 2021 Feb; 41(1):157-166. PubMed ID: 33522209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: a randomized, controlled and double-blinded prospective trial].
    Feng YL; Ling CQ; Zhu DZ; Yu CQ; Chen Z; Li B
    Zhong Xi Yi Jie He Xue Bao; 2005 Mar; 3(2):99-102. PubMed ID: 15763053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization.
    Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Nagai K; Nakagawa T; Sugawara T; Hanaoka H; Kanai F; Yokosuka O
    Hepatology; 2018 Feb; 67(2):575-585. PubMed ID: 28746788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study.
    Sainamthip P; Kongphanich C; Prasongsook N; Chirapongsathorn S
    World J Clin Cases; 2021 Oct; 9(30):9059-9069. PubMed ID: 34786388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese Herbal Medicine (Chaihu-Huaji Decoction) Alleviates Postembolization Syndrome following Transcatheter Arterial Chemoembolization and Improves Survival in Unresectable Hepatocellular Cancer: A Retrospective Study.
    Xu H; Deng Y; Zhou Z; Huang Y
    Evid Based Complement Alternat Med; 2019; 2019():6269518. PubMed ID: 30854013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hepatic functional reserve injury after TACE in hepatocellular carcinoma with Chinese herbal medicines].
    Chen XX; Zhang B; Zhang YQ; Hung GX; Chen MS; Guo RP; Lin XJ; Hu PL; Qiu HJ; Xu BP
    Ai Zheng; 2002 May; 21(5):547-9. PubMed ID: 12452052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and experimental study of xiaoshui decoction in the treatment of primary liver cancer caused ascites].
    Wu D; Bao WG; Ding YH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1066-9. PubMed ID: 16398423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo.
    Pinter M; Ulbrich G; Sieghart W; Kölblinger C; Reiberger T; Li S; Ferlitsch A; Müller C; Lammer J; Peck-Radosavljevic M
    Radiology; 2015 Dec; 277(3):903-12. PubMed ID: 26131911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
    Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.